Status:

COMPLETED

Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With Osteoporosis

Lead Sponsor:

Dentsply Sirona Implants and Consumables

Conditions:

Postmenopausal Osteoporosis

Osteopenia

Eligibility:

FEMALE

60+ years

Phase:

NA

Brief Summary

The overall objective of the study is to compare treatment with the ASTRA TECH Implant System, OsseoSpeed™ implant in the maxilla of postmenopausal women with and without systemic osteoporosis. The hy...

Eligibility Criteria

Inclusion

  • Provision of informed consent
  • Postmenopausal women aged 60 years and over
  • In need of 2-8 implants in maxilla
  • A history of edentulism in the area of implant treatment of at least 6 months.
  • A Bone Mineral Density (BMD) value suitable either for group A or group B:
  • Group A (Osteoporosis/osteopenia): BMD at least 2 standard deviations (SD) below mean peak bone density of young adults for the spine and total hip (T-score = -2 SD or less). Absolute values (g/cm2) will be used.
  • Group B (Control): BMD not more than 1 standard deviation below mean peak bone density of young adults for the spine and total hip (T-score = -1 SD or more). Absolute values (g/cm2) will be used.

Exclusion

  • Unlikely to be able to comply with study procedures, as judged by the investigator.
  • Untreated, uncontrolled caries and/or periodontal disease
  • Known or suspected current malignancy
  • History of chemotherapy within 5 years prior to surgery
  • History of radiation in the head and neck region
  • History of other metabolic bone diseases, e.g. Paget's disease, hyperparathyroidism, fibrous dysplasia or osteomalacia
  • A medical history that makes implant insertion unfavourable
  • Need for systemic corticosteroids
  • Current or previous use of intravenous bisphosphonates (esp. zoledronic acid)
  • Current or previous use of oral bisphosphonates
  • History of bone grafting and/or sinus lift in the planned implant area
  • Current need for bone grafting and/or sinus lift in the planned implant area
  • Present alcohol and/or drug abuse
  • Involvement in the planning and conduct of the study (applies to both Astra Tech AB staff or staff at the study site)
  • Previous enrolment in the present study.
  • Participation in a clinical study during the last 6 months.

Key Trial Info

Start Date :

July 16 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 15 2017

Estimated Enrollment :

103 Patients enrolled

Trial Details

Trial ID

NCT00745121

Start Date

July 16 2008

End Date

November 15 2017

Last Update

November 26 2019

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Department of Periodontology, Faculty of Medicine, Catholic University of Leuven

Leuven, Belgium, B-3000

2

Zahnklinik

Würzburg, Germany, DE-97070

3

Department of Oral and Maxillofacial Surgery, Gothenburg University

Gothenburg, Sweden, SE-405 30

4

Käkkirurgiska kliniken, Akademiska sjukhuset

Uppsala, Sweden, S-751 85